At Novoviah, we make monitoring for rare antigen-specific T cells easy and sensitive for a clinical trial.
Arising from our Founder’s 20+ years’ experience researching and studying celiac disease and inflammatory bowel diseases, Novoviah’s break-through foundation product is the proprietary Novoleukin Test System, a “whole blood antigen-stimulated cytokine release assay” which is substantially more sensitive than conventional fresh PBMC-based ELISpot assay and flow cytometry assays.
Novoviah has demonstrated the success of the Novoleukin Test System as a ‘research only product’, firstly in Celiac Disease (Novoleukin-C, clinical validation stage); and is expanding to Type 1 Diabetes, and other medical conditions associated with antigen-specific T cells.
Novoviah’s aspiration is to have a Novoleukin Test System available for a wide range of antigens relevant to immune disease, immunotherapies and vaccines, and to explore their clinical utility as diagnostics or monitoring tools.
If you are a pharmaceutical or research company developing therapeutics or monitoring tools for indications where specific disease-associated antigen and T cell responses are implicated, contact us to discuss development of a highly sensitive Novoleukin Test System specific to your indication.
Company Details
- Employees
- 13
- Founded
- 2020
- Address
- 200 Adelaide St, Level 6,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.novoviah.com
- Keywords
- Biotechnology, Diagnostics, Biomarkers, Immunotherapy, Autoimmune, Type 1 Diabetes, Melanoma, Celiac Disease, Solid Tumors.
- HQ
- Brisbane City, Queensland
Novoviah - Ultra-Sensitive T Cell Testing In Patients Questions
Novoviah - Ultra-Sensitive T Cell Testing In Patients's website is http://www.novoviah.com
Novoviah - Ultra-Sensitive T Cell Testing In Patients's LinkedIn profile is https://au.linkedin.com/company/novoviah
Novoviah - Ultra-Sensitive T Cell Testing In Patients has
13 employees.
View email and phone details for 13
employees at Novoviah - Ultra-Sensitive T Cell Testing In Patients.
Novoviah - Ultra-Sensitive T Cell Testing In Patients's industry is
Biotechnology Research
Novoviah - Ultra-Sensitive T Cell Testing In Patients's top competitors are
Jm Clinical,
De Groot Technical Services,
Novotech,
Uq Women In Science Association,
Cpl Biotech Inc,
Ke Select - Scientific & Medical Recruitment Specialists,
Inia Health / Mindcheck,
Bristol Myers Squibb,
Funky Fungus,
Mater Adult Hospital.
Novoviah - Ultra-Sensitive T Cell Testing In Patients's categories are Biotechnology Research
Novoviah - Ultra-Sensitive T Cell Testing In Patients's founding year is 2020
